Holiday notice: from 1pm Monday 21 September, all orders will be dispatched on Tuesday 29 September. Order as normal — everything ships the day we're back. Thank you!

Brand new — selective amylin receptor agonist supplied as a 10mg lyophilised vial for in vitro receptor research. Limited UK stock.
Best value and fastest option — supplied as a lyophilised vial, dispatched same day on orders before 1pm. Use our calculator for your target concentration.
For In Vitro Use Only — Not for Human Use
Every batch is independently HPLC & mass-spec tested. Certificate of Analysis is batch-numbered and matched to the vial you receive.
Eloralintide is a synthetic, long-acting amylin analogue that acts selectively at amylin receptors. Amylin signalling is a distinct pathway from the GLP-1, GIP and glucagon receptor pathways targeted by incretin-class research peptides such as Semaglutide, Tirzepatide and Retatrutide. Supplied as a 10mg sterile lyophilised powder.
Amylin is a separate peptide hormone co-secreted with insulin by pancreatic beta cells. Its receptors are formed by the calcitonin receptor paired with receptor activity-modifying proteins (RAMPs) — a different receptor family from GLP-1, GIP and glucagon receptors. Eloralintide is used in vitro to study selective amylin receptor activation, selectivity versus the calcitonin receptor, and comparator pharmacology alongside incretin-class peptides.